Search Job Title Only
News By Subject
News by Disease
News By Date
Get Our FREE
Lifts Warning On Eatontown Facility
4/2/2014 7:03:59 AM
Hikma Pharmaceuticals Plc said on Wednesday that the U.S. Food and Drug Administration had lifted the warning on its Eatontown facility in New Jersey where it makes oral products for the U.S. market. The Jordanian company, which makes and markets branded and non-branded generics and injectibles, said it was gradually reintroducing products to the U.S. market from the facility. The company had suspended manufacturing at the plant in 2012 after receiving an FDA warning letter.
Help employers find you! Check out all the
post your resume
Delivers An Excellent Performance In 2013 With Group Revenue Growth Of 23% And EPS Up 111%
Finds Contaminated Drug Ingredient At
(GSK) Ireland Plant
(GSK) Recalls Weight-Loss Drug Alli In U.S. After Tampering
(UNIS) Rockets On $40 Million
Supply Deal; Stock Up +31.71% on Wednesday at 12:13ET
Warning Letter Resurrects Issue Of
Intuitive Surgical, Inc.
(ISRG) Surges After
Approves New Robot Device
(SHPG) Recalls A Batch Of Gaucher Disease Drug VPRIV®
(ABT)'s Supera Stent To Treat Peripheral Artery Disease
More Trouble As
(RANBAXY.BO) Recalls More Than 60,000 Bottles Of Generic Lipitor In U.S.
comments powered by Disqus.
comments powered by
Food and Drug Administration (FDA)
Clinical - Recalls and Warnings
Clinical - Recalls and Warnings (World)